Opterion Health AG Initiates Phase 1 SPARC Trial After OPT101
23 Feb 2026 //
GLOBENEWSWIRE
Opterion Health AG Names Andreas Schuh as CFO
01 Dec 2025 //
GLOBENEWSWIRE
Opterion Submits CTA For First-in-Human OPT101 In Advanced CKD
17 Sep 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support